HTR2B and gestational diabetes: Although pharmacological inhibition of the HTR2B receptor has been previously shown to induce gestational diabetes in pregnant mice9, our study is the first to use an HTR2B agonist to increase β-cell proliferation and improve glucose tolerance during pregnancy.